2024 IMPAACT Annual Meeting
Thanks for joining us at the 2024 IMPAACT Annual Meeting!
The hybrid event brought together IMPAACT Network leadership, investigators, research site staff, community advocates, and network affiliates to discuss the network's scientific agenda and explore innovative approaches to future research. Representing 47 research sites across 12 countries, the six-day meeting was filled with engaging presentations, collaborative sessions, and networking activities, providing an opportunity to share lessons learned, inspire implementation strategies, and sharpen operational best practices.
Recordings and presentations will be posted as they are made available.
Recordings and Presentations
Sunday, 22 September 2024
IMPAACT Community Advisory Board Meetings
- History of CABs and HIV Activism – Russell Campbell and Rona Siskind
- Effective Utilization of People First Language – Rona Siskind
- CAB Utilization Forum: Lessons Learned – Emanueli Sereki Msuya
- Considerations for Analytical Treatment Interruption – Dr. Mark Cotton
Monday, 23 September 2024 (Recording)
IMPAACT Community Advisory Board Plenary I
- State of the Network: The Way Forward for IMPAACT – Dr. Sharon Nachman
- Milestone to HIV Cure – Jessica Salzwedel
- Integration of Wellbeing into HIV prevention and Treatment Research and Practice – K Rivet Amico
IMPAACT Community Advisory Board Plenary II
- Understanding the Unique Challenges of Cisgender Women Living with HIV – Dr. Rachel Scott
- Preparing the Next Generation: Building Research Capacity for Youth CAB Representatives – Doreen Kemigisha
- Person Centered Trauma Informed Care – Jonathan Lucas
IMPAACT Community Advisory Board Plenary II
- Addressing HIV Stigma in Healthcare Environments – Dr. Laura Nyblade
- Diversifying Treatment Options for Pregnant People with Syphilis – Dr. Jason Zucker
- Chest Feeding Guidelines for People Living with HIV – Dr. Lisa Abuogi
- Introduction to the Data Management Center (DMC) – Marlene Cooper
Tuesday, 24 September 2024 (Recording)
IMPAACT Annual Meeting Plenary Session I
- DAIDS Update and Network Re-Competition – Carl Dieffenbach, PhD
- State of the Network – Sharon Nachman, MD
- Congenital Syphilis Enduring Pandemic – Juan C. Salazar, MD, MPH
- Tuberculosis Vaccine Landscape – Lisa Marie Cranmer, MD, MPH
- Lenacapavir Update in Pregnancy – Cristoph Carter, MD, PhD
- Antiretrovirals in Pregnancy Research: WHO Toolkit – Elaine Abrams, MD and Shanin Lockman, MD
Wednesday, 25 September 2024 (Recording)
IMPAACT Annual Meeting Plenary Session II
- Study Design Considerations for Efficacy Trials of Infant Postnatal Prophylaxis Against HIV – Dwight E. Yin, MD, PhD and Mark Giganti, PhD
- The Debate: Long-Acting ARVs vs. Broadly Neutralizing Antibodies for Postnatal Prophylaxis – Moherndran Archary, MBChB, PhD and Mark Cotton, MMeD, PhD and Theodore Ruel, MD and Betsy McFarland, MD
- Pharmacokinetics and Safety of Dolutegravir in Neonates Exposed to HIV-1 (IMPAACT 2023) – Jeremiah Momper, PharmD, PhD
- P1108: Impact on Global Policy and Access for Bedaquiline in Children – Anneke Hesseling, MBChB, MSc, PhD
- IMPAACT 2009 Updates – Benjamin Chi, MD, MSc
- Maternal Plasma Inflammatory Markers as a Predictive Biomarker for Adverse Pregnancy Outcomes in Women on Antiretroviral Therapy – Taguma Allen Matubu, PhD
- Growth Factors and Growth Faltering in HIV Exposed Uninfected Children – Brenda Kakayi, BPharm
- Indoleamine 2, 3-dioxygenase as a Tuberculosis Biomarker in Pregnant People Living with HIV – Clement Gascua Adu-Gyamfi, PhD
- Network Awards – Philippa Musoke, MBChB, PhD
IMPAACT Scientific Committee Meeting
Therapeutics (Recording)
- Alternative Therapies for Treatment of Syphilis – Carolyn D. Deal, PhD
- Challenges of Pharmacokinetics in Pregnancy – Robert R. Bies, PharmD, PhD, FISoP, FACCP
- Breastfeeding HIV Transmission and Prophylaxis – Grace Aldrovandi, MD, CM
- Community Perspectives from Uganda and South Africa: Breastfeeding in People Living with HIV – Thabo Makete and Nakitto Aisha Gava
Thursday, 26 September 2024
IMPAACT Scientific Committee Meeting
Tuberculosis
- Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium – Rada Savic, PhD, MBA
- Update on TBSC: Highlights, Impact, and the Future – Anneke C. Hesseling, MD, PhD and Amita Gupta, MD, MHS (RECORDING)
- The pre-adolescent TB vaccine landscape beyond 2035 – Lisa Marie Cranmer, MD, MPH
- Recruitment challenges and levofloxacin acceptability in the TB-CHAMP MDR-TB prevention trial – Susan Purchase, MBChB (RECORDING)
- Novel Methods to Assess Acceptability of TB Drug Formulations in Children – Dillon Wademan, PhD, MA (RECORDING)
- WHO Maternal TB Working Group and Update on WHO/IMPAACT/SMART4TB Progress – I.D. Rusen, MD, MSc (RECORDING)
- The discovery of monitoring biomarkers from the SHINE study – Claire Dunican, PhD (RECORDING)
- Host blood transcriptomic signatures for paediatric tuberculosis treatment monitoring – Vanessa Muwanga (RECORDING)
Save the Date!
Join us 7-12 September 2025 at the Crystal Gateway Marriott in Arlington, Virginia for the next IMPAACT Annual Meeting.
